# Ovarian Sertoli-Leydig Cell Tumors in a Three-Year-Old Child

**Authors:** Hatim Jabri, Fatoumata Binta Balde, Mohammed Mahmoud, Othmane Alaoui, Abdelhalim Mahmoudi, Khalid Khatalla, Youssef Bouabdallah

PMC · DOI: 10.7759/cureus.63554 · 2024-07-01

## TL;DR

A rare ovarian tumor causing virilization in a three-year-old girl is reported, highlighting the importance of considering this condition in young girls with similar symptoms.

## Contribution

This case report presents the youngest known case of ovarian Sertoli-Leydig cell tumor, expanding clinical awareness for early diagnosis.

## Key findings

- Ovarian Sertoli-Leydig cell tumors can present in very young children with virilization and abdominal mass.
- Early diagnosis and histological evaluation are crucial for determining prognosis and treatment.
- This case expands the known age range for such tumors and emphasizes the need for prompt clinical evaluation.

## Abstract

Ovarian Sertoli-Leydig cell tumors (SLCT) are extremely rare malignant tumors deriving from the sex cord stroma. An abdominal mass and a virilization syndrome dominate the clinical symptoms. This particular tumor poses diagnostic and therapeutic problems. Prognosis depends on staging (the International Federation of Gynecology and Obstetrics (FIGO)/tumor, node, metastasis (TNM)) and differentiation. The treatment is surgical, combined with adjuvant chemotherapy in certain cases.

We report the case of a three-year-old girl admitted to our department for signs of virilization with an abdominal mass. The literature does not contain any reports of a younger case. Ovarian SLCTs should be considered in every girl presenting with signs of virilization and a lower abdominal mass. The prognosis and management depend on the results of the histological analysis and extension evaluation in order to define therapeutic management.

## Full-text entities

- **Diseases:** abdominal mass (MESH:D000007), Ovarian Sertoli-Leydig Cell Tumors (MESH:D010051), TNM (MESH:D008207), virilization syndrome (MESH:D014770), SLCT (MESH:D018310), malignant tumors (MESH:D009369)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11289655/full.md

---
Source: https://tomesphere.com/paper/PMC11289655